AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the ...
Remarkable but responsible creative work. We’re most passionate about the pursuit of original, powerful ideas that our clients can harness to unlock their brand’s potential. But, and here’s the USP, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results